0001104659-24-065215.txt : 20240524 0001104659-24-065215.hdr.sgml : 20240524 20240524210140 ACCESSION NUMBER: 0001104659-24-065215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240524 FILED AS OF DATE: 20240524 DATE AS OF CHANGE: 20240524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY WILLIAM GARRETT CENTRAL INDEX KEY: 0001692961 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38128 FILM NUMBER: 24986082 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc. CENTRAL INDEX KEY: 0001651407 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472568632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 95 SAWYER ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 95 SAWYER ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 tm2415549-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-05-24 0 0001651407 Checkpoint Therapeutics, Inc. CKPT 0001692961 GRAY WILLIAM GARRETT 95 SAWYER RD, SUITE 110 WALTHAM MA 02453 0 1 0 0 Chief Financial Officer 0 Common Stock (Restricted) 2024-05-24 4 A 0 540000 0.00 A 685224 D The shares of restricted stock vest as follows: one-third on January 31, 2025, one-third on January 31, 2026 and one-third on January 31, 2027. Includes shares of restricted common stock, which vest over various time periods. /s/ Garrett Gray 2024-05-24